AVALO THERAPEUTICS INC (AVTX)

US05338F3064 - Common Stock

6.52  -0.35 (-5.09%)

After market: 6.5 -0.02 (-0.31%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
820.00K1.92M18.05M5.40M6.70M
Cost Of Goods
-754.00K1.28M3.43M1.49M300.00K
Gross Profit
1.57M640.00K14.62M3.91M6.40M
Operating Expenses
38.11M24.08M52.06M86.04M53.69M
Research and Development
20.24M13.78M31.31M59.84M32.19M
Selling, General, and Administrative Expenses
17.88M10.30M20.71M24.66M19.76M
Operating Income
-36.54M-23.44M-37.44M-82.13M-47.29M
Interest Income/Expense
-4.70M-4.14M-4.17M-2.39M5.26M
Other Income/Expense
-28.93M-42.00K-20.00K-20.00K410.00K
Non Recurring Items
-59.09M-3.91MN/A0.00-25.55M
Income Before Taxes
-129.25M-31.53M-41.63M-84.55M-67.18M
Income Tax
-2.00K14.00K30.00K-200.00K-2.79M
Net Income
-35.32M-31.54M-41.66M-84.38M-63.50M
EBITDA
-36.40M-23.29M-37.27M-80.47M-45.45M
 
Per Share Data
EPS Diluted Total Ops
-38.40-113.58-4.43-10.13-11.42
Non GAAP EPS
-272.53-488.22-253.04-9.96-10.56
 
Statistics
Gross Profit Margin
191.95%33.26%81.00%72.41%95.52%
Profit Margin
-4306.83%-1639.50%-230.80%-1562.59%-947.76%
Operating Profit Margin
-4455.98%-1218.50%-207.42%-1520.93%-705.82%

All data in USD

Charts